Current Rheumatology Reports

, 16:405

Management of Recurrent Thrombosis in Antiphospholipid Syndrome

  • Cecilia Nalli
  • Laura Andreoli
  • Cinzia Casu
  • Angela Tincani
ANTIPHOSPHOLIPID SYNDROME (D ERKAN, SECTION EDITOR)

DOI: 10.1007/s11926-013-0405-4

Cite this article as:
Nalli, C., Andreoli, L., Casu, C. et al. Curr Rheumatol Rep (2014) 16: 405. doi:10.1007/s11926-013-0405-4
Part of the following topical collections:
  1. Topical Collection on Antiphospholipid Syndrome

Abstract

One of the challenges of managing patients with antiphospholipid syndrome is the prevention of rethrombosis (secondary prophylaxis). Risk stratification, i.e. traditional cardiovascular and thrombosis risk factors, systemic autoimmune diseases, antiphospholipid antibody profile, and the intensity of anticoagulation are all relevant to the management of APS patients with recurrent thrombosis. The paper will review “state of the art” strategies for optimizing therapy for APS patients with recurrent thrombosis.

Keywords

Antiphospholipid antibodiesAnticardiolipin antibodiesAnti-β2glycoprotein I antibodiesLupus anticoagulantThrombosisRecurrent thrombosisStrokePrimary antiphospholipid syndromeCardiovascular risk factorsWarfarinLow-dose aspirinHydroxychloroquineStatinsHeparinRituximabManagement

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Cecilia Nalli
    • 1
    • 2
    • 3
  • Laura Andreoli
    • 1
    • 3
  • Cinzia Casu
    • 4
    • 5
  • Angela Tincani
    • 1
    • 3
  1. 1.Rheumatology and Clinical Immunology, Department of Clinical and Experimental SciencesSpedali Civili and University of BresciaBresciaItaly
  2. 2.Rheumatology ChairUniversity of PaviaPaviaItaly
  3. 3.BresciaItaly
  4. 4.Rheumatology UnitNiguarda “Ca’ Granda” HospitalMilanItaly
  5. 5.MilanItaly